注射用盐酸土霉素的细菌内毒素检查

参照<中国兽药典>二○○○年版一部附录细菌内毒素检查法,研究了注射用盐酸土霉素对细菌内毒素检测的干扰情况,确定0.312 5 mg/mL浓度的供试品溶液对检测无干扰作用,建立了注射用盐酸土霉素的细菌内毒素限量检查方法.     

Pharmacokinetics of articaine hydrochloride and its metabolite articainic acid after subcutaneous administration in red deer (Cervus elaphus)

AIM: To develop and validate a simple and sensitive method using liquid chromatography-mass spectrometry (LC-MS) for quantification of articaine, and its major metabolite articainic acid, in plasma of red deer (Cervus elaphus), and to investigate the pharmacokinetics of articaine hydrochloride and articainic acid in red deer following S/C administration of articaine hydrochloride as a complete ring block around the antler pedicle.

METHODS: The LC-MS method was validated by determining linearity, sensitivity, recovery, carry-over and repeatability. Articaine hydrochloride (40?mg/mL) was administered S/C to six healthy male red deer, at a dose of 1?mL/cm of pedicle circumference, as a complete ring block around the base of each antler. Blood samples were collected at various times over the following 12 hours. Concentrations in plasma of articaine and articainic acid were quantified using the validated LC-MS method. Pharmacokinetic parameters of articaine and articainic acid were estimated using non-compartmental analysis.

RESULTS: Calibration curves were linear for both articaine and articainic acid. The limits of quantifications for articaine and articainic acid were 5 and 10?ng/mL, respectively. Extraction recoveries were >72% for articaine and >68% for articainic acid. After S/C administration as a ring block around the base of each antler, mean maximum concentrations in plasma (C_max) of articaine were 1,013.9 (SD 510.1) ng/mL, detected at 0.17 (SD 0.00) hours, and the C_max for articainic acid was 762.6 (SD 95.4) ng/mL at 0.50 (SD 0.00) hours. The elimination half-lives of articaine hydrochloride and articainic acid were 1.12 (SD 0.17) and 0.90 (SD 0.07) hours, respectively.

CONCLUSIONS AND CLINICAL RELEVANCE: The LC-MS method used for the quantification of articaine and its metabolite articainic acid in the plasma of red deer was simple, accurate and sensitive. Articaine hydrochloride was rapidly absorbed, hydrolysed to its inactive metabolite articainic acid, and eliminated following S/C administration as a ring block in red deer. These favourable pharmacokinetic properties suggest that articaine hydrochloride should be tested for efficacy as a local anaesthetic in red deer for removal of velvet antlers. Further studies to evaluate the safety and residues of articaine hydrochloride and articainic acid are required before articaine can be recommended for use as a local anaesthetic for this purpose.     

黄连中盐酸小檗碱的提取纯化及抑菌活性研究

为了探究盐酸小檗碱在植物病原真菌方面的抑制作用,以黄连根粉为材料,采用酸水法提取和乙醇重结晶获得盐酸小檗碱纯品,采用生长速率法研究了盐酸小檗碱对常见植物病原菌的抑制活性。结果表明,盐酸小檗碱的提取率为3.3%,经高效液相色谱法测得其含量为93.56%;抑菌活性试验表明,盐酸小檗碱在100μg/mL时对玉米大斑病菌的抑制率达99.9%,EC_(50)为8.20μg/mL,表现出比药剂对照噁霉灵和百菌清更高的抑制活性;进一步的试验表明,与噁霉灵及百菌清相比,盐酸小檗碱对玉米大斑病菌的抑制作用具有持效期长的特点。     

口服盐酸特比萘芬对幼犬血液常规及生化指标的影响

试验表明,盐酸特比萘芬不同饲喂剂量均可导致犬淋巴细胞百分比、中性粒细胞百分比、白细胞数等血常规检测指标异常。盐酸特比萘酚在幼犬肝脏和肾脏中的毒性是慢性累积的,临床应用中推荐使用盐酸特比萘芬剂量为 5 mg/kg.d进行口服,连续给药不能超过 21d。     

土霉素在黑鲷体内的药物代谢动力学研究

首次报道了黑鲷口服土霉素的药物代谢动力学特征，用高效液相色谱法测定组织中的药物含量，药物在肌肉，血液，肝脏中的平均回归率分别为８５.61%,85.38%,82.005,该方法的检测限可达0.01μg/g，黑鲷１次口服剂量为７５mg/kg的土壤素后，其血液药物浓度－时间数据符合一室开放动力学模型，吸收速率常数（ka)为０.296/h，达峰时间（Ｔamx)为１０.635h,峰浓度（Ｃmax)为１.398μg/ml, 分布半衰期（Ｔ１／２a）为２.339h ,消除半衰期(T1/20β）为46.663h，药时曲线下面积（ＡＵＣ）为１１0.25mg/L.h，黑绸口服药物０.5h后在血液，肥肉，肝脏，肾脏４种组织中就可以检测到药物的存在，药物在１６h的采样点浓度达最高，分别为1.68μg/ml,1.68,2.52,6.77μg/g。     

盐酸小檗碱对草鱼补体系统及补体c3作用的研究

为了探究盐酸小檗碱(berberine hydrochloride)对草鱼(Ctenopharyngodon idellus)补体c3的作用机理,用含0、0.06%、0.12%、0.24%盐酸小檗碱饲料投喂草鱼,在第7 d、14 d检测血清中补体c3含量,在第14 d检测肝脏中补体c3 mRNA表达量及急性感染嗜水气单胞菌(Aeromonas hydrophila)后存活情况。并进一步对盐酸小檗碱体内药代动力学和补体消耗试验进行了研究。结果显示;摄食盐酸小檗碱的草鱼血清中补体c3含量和肝脏补体c3 mRNA表达量均显著性增加(P0.05/P0.05),草鱼的存活率与对照组相比也有显著性提高(P0.01)。补体消耗试验结果显示,当盐酸小檗碱在血清中浓度小于5 mg/L时与对照组相比补体消耗不显著,当盐酸小檗碱浓度大于5 mg/L时,补体消耗达到显著性差异(P0.05),表明此时盐酸小檗碱与补体c3直接结合,激活补体。药代动力学实验发现,灌服盐酸小檗碱后,出现双峰现象,两峰值分别是0.243 mg/L和0.117 mg/L,此浓度远远低于与补体c3直接结合量最低量(5 mg/L)。结果表明,盐酸小檗碱对草鱼补体c3的作用机理可能是通过上调补体c3mRNA的表达增加补体c3数量,而非通过直接结合补体c3来改变其活性。     

Pharmacokinetics of oxolinic acid and oxytetracycline in kuruma shrimp, Penaeus japonicus

The pharmacokinetics of oxolinic acid and oxytetracycline were examined in kuruma shrimp (Penaeus japonicus) after intra-sinus (10 and 25 mg/kg, respectively) and oral (50 mg/kg) administration. The shrimp were kept in tanks with recirculated artificial seawater at a salinity of 22–23 ppt. The water temperature was maintained at 25±0.6 °C. The hemolymph concentrations of both drugs after intra-sinus dosing were best described by a two-compartment open model. The distribution and elimination half-lives (t_1/2 and t_1/2β) were found to be 0.59 and 33.2 h for oxolinic acid and 0.45 and 24.7 h for oxytetracycline, respectively. The apparent volume of distribution at a steady state (V_ss) and total body clearance (CL_b) were estimated to be 1309 ml/kg and 28.8 ml/kg/h for oxolinic acid and 748 ml/kg and 22.7 ml/kg/h, respectively. The hemolymph concentration–time curves after oral administration did not fit by the nonlinear least squares method using one- and two-compartment model with first-order absorption in either of the drugs. The peak hemolymph concentration (C_max), the time to peak hemolymph concentration (t_max) and the elimination half-life were found to be 17.8 μg/ml, 7 h and 34.3 h for oxolinic acid and 24.3 μg/ml, 10 h and 33.6 h for oxytetracycline, respectively. The bioavailability (F) after oral administration was 32.9% for oxolinic acid and 43.2% for oxytetracycline. The hemolymph protein binding in vivo was determined to be 36.7±8.5% for oxolinic acid and 22.9±4.8% for oxytetracycline.     

盐酸环丙沙星搽剂的研制及临床应用试验

环丙沙星是高效广谱抗菌新药,将其同透皮吸收促进剂（Ａｚｏｎｅ）按药剂学方法制成盐酸环丙沙星搽剂,稳定性良好．将药液涂搽于仔猪体表,用以防治哺乳仔猪大肠杆菌病,获得满意效果．     

堆肥中土霉素和金霉素的液相色谱荧光检测方法

[目的]建立一种快速、简便、灵敏的堆肥中土霉素和金霉素残留的检测方法。[方法]采用高效液相色谱（HPLC）荧光检测法检测堆肥中的土霉素和金霉素残留,以V（咪唑缓冲溶液）∶V（甲醇）=80∶20（pH=5）为流动相,C18柱分离,用苯乙烯二乙烯苯共聚物小柱富集,净化。[结果]土霉素和金霉素的检出限分别为0.02、0.04mg/L;土霉素加标量为0.02、0.05、0.10mg/L时的回收率为78.0%～91.5%,方法的RSD为2.1%～7.9%,金霉素加标量为0.04、0.10、0.20mg/L时的回收率为87.5%～93.5%,方法的RSD为4.3%～6.5%。[结论]采用高效液相色谱荧光检测法检测堆肥中的土霉素和金霉素具有灵敏度高、稳定性好、简便易行等优点,且被测组分可得到较好的分离。     

复方盐酸土霉素注射液的制备

【目的】制备复方盐酸土霉素注射液,并对其质量浓度进行测定。【方法】通过预试验,确定复方盐酸土霉素注射液的配方组分及其大致用量。以焦亚硫酸钠、MgCl2、乙醇胺和复合有机溶媒为影响因素,以灭菌前后盐酸土霉素和甲硝唑质量浓度变化为考察指标,利用L9(34)正交试验确定复方注射液的最优配方。利用紫外分光光度法对注射液中甲硝唑和盐酸土霉素的质量浓度进行考察,并计算其回收率和精密度。【结果】复方盐酸土霉素注射液的最优配方为:每100mL注射液中含有2.5g甲硝唑、5.0g盐酸土霉素、3g氯化镁、0.2g焦亚硫酸钠、40mL复合有机溶媒(由N,N-二甲基甲酰胺和聚乙二醇400组成,体积比为2∶1)、4mL乙醇胺,其余为注射用水。甲硝唑和盐酸土霉素在1～30μg/mL质量浓度时与吸光度呈现良好的线性关系。制备的复方盐酸土霉素注射液中甲硝唑的平均回收率为(99.22±1.48)%,变异系数为1.49%;盐酸土霉素的平均回收率为(98.22±1.24)%,变异系数为1.26%。注射液中甲硝唑和盐酸土霉素的日内、日间精密度测定结果为:平均质量浓度较高,相对标准偏差较小,且不大于2.00%。【结论】确定的复方盐酸土霉素注射液配方合理,甲硝唑和盐酸土霉素稳定性好,且回收率高。